CROVALIMAB

UNII: H9KH1GP3UU
Preferred Substance Name: CROVALIMAB

1917321-26-6
COMPLEMENT C5 INHIBITORY HUMANIZED RECYCLING MONOCLONAL ANTIBODY (RG-6107 )
CROVALIMAB [INN]
CROVALIMAB [JAN]
CROVALIMAB [USAN]
CROVALIMAB [WHO-DD]
CROVALIMAB-AKKZ
IMMUNOGLOBULIN G1, ANTI-(HUMAN COMPLEMENT C5)(HUMANIZED RO7112689 HEAVY CHAIN), DISULFIDE WITH HUMANIZED RO7112689 LIGHT CHAIN, DIMER
PIASKY
RG6107
RG-6107
RO7112689
RO-7112689
SKY59
SKY-59

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

CROVALIMAB

Synonyms and Mappings

Resources

Note